AMENDMENT TO CONSULTING aGREEMENTFourth Amendment • March 30th, 2022 • RenovoRx, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2022 Company IndustryThis Fourth Amendment (the “Fourth Amendment”) by and between RenovoRx, Inc. (the “Company”) and Ramtin Agah (“Consultant”) (together, the “Parties”) amends the Consulting Agreement by and between the Parties dated January 1, 2018 (“Consulting Agreement”), as amended by the Second Amendment to the Consulting Agreement, effective August 1, 2019 (the “Second Amendment”), and the Third Amendment to the Consulting Agreement, effective November 11, 2021 (the “Third Amendment”, and together with the Second Amendment (as amended by the Third Amendment) and the Consulting Agreement, the “Agreement”). This Amendment is entered into as of January 25, 2022 (“Amendment Effective Date”).